Bilirubin as a Biomarker in Liver Disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F16%3A10329726" target="_blank" >RIV/00064165:_____/16:10329726 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/16:10329726

Výsledek na webu

<a href="http://link.springer.com/referenceworkentry/10.1007/978-94-007-7742-2_25-1" target="_blank" >http://link.springer.com/referenceworkentry/10.1007/978-94-007-7742-2_25-1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-94-007-7742-2_25-1" target="_blank" >10.1007/978-94-007-7742-2_25-1</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Bilirubin as a Biomarker in Liver Disease

Popis výsledku v původním jazyce

Bilirubin had been studied since the eighteenth century because assessment of serum bilirubin concentration is important in the diagnosis and prognosis of patients with liver disorders. All prognostic scores for liver diseases include bilirubin in their calculations, and some studies have shown that bilirubin is an independent biomarker of mortality risk. We know that a high total bilirubin level is an indicator of disease, but nowadays there is evidence indicating the association of a low level with increased risk of diseases, for example, cancer or cardiovascular disorders. Bilirubin is a potential biomarker because its concentration is associated with mortality and may also be associated with the prevention of disease. This chapter will review the usefulness of bilirubin as a marker in liver diseases and their possible use to assess outcomes and risk of other non-liver diseases.

Název v anglickém jazyce

Bilirubin as a Biomarker in Liver Disease

Popis výsledku anglicky

Bilirubin had been studied since the eighteenth century because assessment of serum bilirubin concentration is important in the diagnosis and prognosis of patients with liver disorders. All prognostic scores for liver diseases include bilirubin in their calculations, and some studies have shown that bilirubin is an independent biomarker of mortality risk. We know that a high total bilirubin level is an indicator of disease, but nowadays there is evidence indicating the association of a low level with increased risk of diseases, for example, cancer or cardiovascular disorders. Bilirubin is a potential biomarker because its concentration is associated with mortality and may also be associated with the prevention of disease. This chapter will review the usefulness of bilirubin as a marker in liver diseases and their possible use to assess outcomes and risk of other non-liver diseases.

Druh

C - Kapitola v odborné knize

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Biomarkers in Liver Disease

ISBN

978-94-007-7742-2

Počet stran výsledku

25

Strana od-do

1-25

Počet stran knihy

400

Název nakladatele

Springer

Místo vydání

Amsterodam

Kód UT WoS kapitoly

—